National Biomedical Research Act (S. 5637)

Where This Stands

Introduced

Committee

Floor Vote

Passed

Signed

Currently IN_COMMITTEE. The next step in the legislative lifecycle is Floor Vote.

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

If passed, this bill would provide a dedicated $10 billion annual stream of funding for medical research and drug regulation, provided that base agency appropriations remain above a specific 'minimum amount' threshold to prevent the fund from replacing standard budget allocations.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

National Institutes of Health

The agency receives a portion of the Fund's annual distributions and must report on the use of these funds.

Food and Drug Administration

The agency receives a portion of the Fund's annual distributions and must report on the use of these funds.

Early career scientists

The bill explicitly authorizes the use of Fund money to support grants and training for early-career researchers.

What changed

Current stage: IN_COMMITTEE.

What's next

Floor Vote.

Summary

This bill creates a new $10 billion annual 'Biomedical Innovation Fund' to provide long-term, stable funding for the National Institutes of Health (NIH) and the Food and Drug Administration (FDA). The money is intended to support high-risk research, early-career scientists, and efforts to address diseases that drive high federal healthcare costs.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

If passed, this bill would provide a dedicated $10 billion annual stream of funding for medical research and drug regulation, provided that base agency appropriations remain above a specific 'minimum amount' threshold to prevent the fund from replacing standard budget allocations.

Frequently Asked Questions

Will this money replace regular funding for the NIH and FDA?

No. The bill includes a 'minimum amount' requirement, meaning the Fund only releases money if the agencies' base remain at or above their highest historical levels since 2025.

What can the money be used for?

Funds are restricted to specific research activities, including basic disease research, disruptive innovation, support for early-career scientists, and improving the efficiency of medical product reviews.

What happens if the money isn't used?

If the distribution requirements are not met for three consecutive years, the accumulated funds are transferred to the general Treasury to help reduce the federal deficit.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Budgetary Insulation

The bill explicitly exempts the new fund from standard discretionary spending limits, a mechanism designed to protect the research budget from broader federal fiscal constraints.

Biomedical Innovation Fund Office of Management and Budget

Connected Entities

organizationAuthorizing Committees“Oversees the fund's operation.”Map →

otherSocial Security Act“Specifically references titles XVIII and XIX for Medicare and Medicaid funding.”Map →

bill_number42 U.S.C. 1397aa et seq.“Reference to State Children's Health Insurance Program”Map →

bill_number42 U.S.C. 1395 et seq.“Reference to Medicare program”Map →

bill_number42 U.S.C. 1396 et seq.“Reference to Medicaid program”Map →

organizationFood and Drug Administration“Related to medical product development and surveillance.”Map →

organizationCommittee on Appropriations of the Senate“Approves funding for the bill.”Map →

organizationCommittee on Appropriations of the House of Representatives“Approves funding for the bill.”Map →

organizationNational Institutes of Health“The primary funding agency for the research outlined in the bill.”Map →

personSecretary of the Treasury“Responsible for distributing funds from the National Biomedical Research Fund.”Map →

personSecretary of Health and Human Services“Oversees the fund's operation.”Map →

otherUnited States Code“References various sections within the United States Code, including 10 U.S.C. C”Map →

Analysis Score

0–100

Significance85
How much this matters to a regular citizen
Controversy40
Intensity of disagreement among stakeholders
Entertainment10
Compellingness for a non-policy-wonk reader
Buzz30
Current news / social attention level